Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma: Correlation with tumor progression and survival

Cancer

Volumn 77, Issue 8 SUPPL., 1996, Pages 1741-1746

  Nakamura, Takeshi ^a   Tabuchi, Yoshiki ^a   Nakae, Siro ^a   Ohno, Masakazu ^a   Saitoh, Yoichi ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

carcinoembryonic antigen; colorectal cancer; nuclear DNA ploidy; proliferating cell nuclear antigen labeling index; survival; tumor progression

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYCLINE; DNA;

ADULT; AGED; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DNA CONTENT; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CELL NUCLEUS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SURVIVAL ANALYSIS;

EID: 0029876697     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1741::AID-CNCR49>3.0.CO;2-X     Document Type: Conference Paper

References (29)

1. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:323-31.
2. Astler VB, Coller FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954;139:846-51.
3. Hutter RVP, Sobin LH. A universal staging for cancer of the colon and rectum. Arch Pathol Lab Med 1986;110:367-8.
4. Jass JR, Atkin WS, Cuzick J, Bussey HJR, Morson BC, Northover JMA, et al. The grading of rectal cancer: historical perspective and multivariate analysis of 447 cases. Histopathology 1969;10:437-59.
5. Tabuchi Y, Deguchi H, Imanishi K, Saitoh Y. Carcinoembryonic antigen levels of peripheral and draining venous blood in patients with colorectal cancer. Cancer 1992;69:2411-7.
6. Kauri M, Nordling S, Kuusela P, Pyrhonen S. Poor prognosis associated with elevated serum CA19-9 level in advanced colorectal carcinoma, independent of DNA ploidy or SPF. Eur J Cancer 1993;29:1691-6.
7. Slentz K, Senagore A, Hibbert J, Mazier WP, Talbott TM. Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg 1994;60:528-31.
8. Hohenberger P, Schlag PM, Gerneth T, Herfarth C. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Ann Surg 1994;219:135-43.
9. Wolley RC, Schreiber K, Koss LG, Karas M, Sherman A. DNA distribution in human colon carcinoma and its relationship to clinical behavior. J Natl Cancer Inst 1982;69:15-22.
10. Armitage NC, Robins RA, Evans DF, Turner DR, Baldwin RW, Hardcastle JD. The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg 1985; 72:823-30.
11. Quirke P, Dixon MF, Clayden AD, Durdey P, Dyson JE, Williams NS, et al. Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinoma. J Pathol 1987;151:285-91.
12. Melamed MR, Enter WE, Banner P, Janov AJ, Kessler G, Darzynkiewicz Z. Flow cytometry of colorectal carcinoma with three-year follow-up. Dis Colon Rectum 1986;29:184-6.
13. Jones DJ, Moore M, Schofield PF. Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study. Br J Surg 1988;75:28-33.
14. Bravo R, Frank R, Blundell PA, Macdonald BH. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987;326:515-7.
15. Mathews MB, Bernstein RM, Franza BR Jr., Garrels JI. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984;309:374-6.
16. Al-Sheneber IF, Shibata HR, Sampalis J, Jothy S. Prognostic significance of proliferating cell nuclear antigen expression in colorectal cancer. Cancer 1993;71:1954-9.
17. Mayer A, Takimoto M, Fritz E, Schellander G, Kofler K, Ludwig H. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer 1993;71:2454-60.
18. Lipponen PK, Eskelinen MJ. Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value. Br J Cancer 1992;66:171-6.
19. Ng IO, Lai EC, Fan ST, Ng M, Chan AS, So MK. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 1994;73:2268-74.
20. Yonemura Y, Kimura H, Fushida S, Tugawa K, Nakai Y, Kaji M, et al. Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy. Cancer 1993;71: 2448-53.
21. Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285-94.
22. Japanese Research Society for Cancer of Colon and Rectum. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. 5th ed. Tokyo: Kanahara, 1994.
23. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-5.
24. Vindelov LL, Christensen IJ, Nissen NI. A detergent trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-7.
25. Hiddemann W, Shumann J, Andreef M, Barlogie B, Herman CJ, Leif RC, et al. Convention on nomenclature for DNA cytometry. Cytometry 1984;5:445-6.
26. Wasseem NH, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): structural conservation and the detection of a nucleolar form. J Cell Sci 1990;96:121-9.
27. Hsu SM, Raine L, Franger H. Use of avidin-biotin-peroxidase complex (ABC) in immunohistochemical techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
28. Umehara Y, Kimura T, Yoshida M, Oba N, Harada Y. Comparison of doubling times of serum carcinoembryonic antigen produced by various metastatic lesions in recurrent gastric and colorectal carcinomas. Cancer 1993;71:4055-9.
29. Takahashi Y, Mai M, Kusama S. Factors influencing growth rate of recurrent stomach cancers as determined by analysis of serum carcinoembryonic antigen. Cancer 1995;75:1497-502.